See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: May 10, 2006

Depression Coronary Artery Disease Multiple Sclerosis

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:


If you are experiencing symptoms of depression, you might be interested in a medical research study for adults, ages 21-64, who experience depression and trouble falling asleep or staying asleep.

If you qualify, all study-related care will be provided at no cost, and you will be compensated up to $275 for time and travel.

The research site is in Jacksonville, Fla.

More information

Please see


Coronary Artery Disease

People with coronary artery disease (CAD) are needed for a research study conducted at St. Vincent's Catholic Medical Centers in New York City.

Eligible participants must be a male or a post-menopausal female between the ages of 55 and 80 and have a confirmed diagnosis of coronary artery disease.

The research site is in New York City.

More information

Please see


Multiple Sclerosis

The purpose of this study is to determine if the combined use of interferon beta 1-a weekly and glatiramer acetate daily as initial treatment for patients with relapsing remitting multiple sclerosis will help reduce relapse rate when compared to either agent alone.

Eligible patients will be required to visit their local clinic every three months over a three-year period -- 15 scheduled visits. All study-related visits and investigational drug therapies are provided at no cost.

Research sites are located throughout the United States.

More information

Please see


Copyright 2006 CenterWatch. All rights reserved.

Consumer News


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.